Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
azilsartan choline
- Development stage
- Approved
- Lead developer
- Hengrui Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
azilsartan choline is a specific salt formulation of azilsartan, a potent and selective non-peptide angiotensin II type 1 (AT1) receptor antagonist (ARB). Developed by Jiangsu Hengrui Medicine, it is intended for the treatment of essential hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor in tissues such as vascular smooth muscle and the adrenal gland, azilsartan inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, thereby reducing peripheral vascular resistance and lowering blood pressure. Clinical development has included Phase 1 studies comparing the pharmacokinetic profile and bioavailability of the choline salt against the parent azilsartan acid and the prodrug azilsartan medoxomil.
- Brand names
- Ruishi
- Other names
- 阿齐沙坦醇铵
02
Targets
AGTR1 (Angiotensin II Type-1 receptor)
Beyond the preview
Go deeper on azilsartan choline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on azilsartan choline.